Business Wire
Quanterix Extends Oncology Footprint with Accelerated Launch of Next Gen SP-X™ Platform and CorPlex™ Validated 10-Plex
Wednesday, 09 January 2019 20:06
Following successful beta program, the Simoa SP-X next generation benchtop and CorPlex are launching ahead of schedule to further revolutionize cancer research, immunotherapy monitoring, and drug development
Read more...
 
Quanterix Extends Oncology Footprint with Accelerated Launch of Next Gen SP-X™ Platform and CorPlex™ Validated 10-Plex
Wednesday, 09 January 2019 20:06
Following successful beta program, the Simoa SP-X next generation benchtop and CorPlex are launching ahead of schedule to further revolutionize cancer research, immunotherapy monitoring, and drug development
Read more...
 
Topix Appoints Brenda Wu as New President & CEO
Wednesday, 09 January 2019 20:06
Skincare and Beauty Industry Veteran to Lead Topix into the Future
Read more...
 
Topix Appoints Brenda Wu as New President & CEO
Wednesday, 09 January 2019 20:06
Skincare and Beauty Industry Veteran to Lead Topix into the Future
Read more...
 
Bioasis Announces the Appointment of Christine Antalik as Chief Financial Officer
Wednesday, 09 January 2019 05:06
Bioasis Technologies, Inc.Catherine London+1-917-763-2709 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Global Hyperkalemia Drugs (Acute & Chronic) Market 2019-2023 - ResearchAndMarkets.com
Wednesday, 09 January 2019 05:06
ResearchAndMarkets.comLaura Wood, Senior Press Manager This e-mail address is being protected from spambots. You need JavaScript enabled to view it For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Liver and Kidney Disorders Drugs
Read more...
 
NantKwest Announces Launch of Merkel Cell Carcinoma Phase II Trial Deploying Novel Triple Combination of off-the-Shelf Natural Killer haNKⓇ Cell Therapy with Superagonist IL-15 Cytokine Therapy and PD-L1 Checkpoint Inhibitor Therapy
Wednesday, 09 January 2019 05:06
Study Tests Elimination Of Chemotherapy And Expands Upon Previous Combination Study Of NK Cell Therapy With N-803 Showing Promising Clinically Meaningful Responses In Merkel Cell Carcinoma Patients
Read more...
 
Elligo Health Research Acquires Protenium Clinical Research; Now over 1 Million Patients Have Access to Research with Elligo
Wednesday, 09 January 2019 05:06
Jane ByramSCORR Marketing512.626.2758 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Seattle Genetics Announces Publication of North American Subgroup Data from ECHELON-1 Phase 3 Clinical Trial of ADCETRIS® (Brentuximab Vedotin) in Newly Diagnosed Advanced Hodgkin Lymphoma
Wednesday, 09 January 2019 05:06
-Data Consistent with ECHELON-1 Trial Outcome Showing Superior Clinical Activity of ADCETRIS in Combination with AVD when Compared to ABVD in Frontline Advanced Hodgkin Lymphoma-
Read more...
 
Artificial Organs - Global Market Analysis, Trends and Forecasts Through 2016-2024: Immunosuppressants Hold Promise in Artificial Organs Market - ResearchAndMarkets.com
Wednesday, 09 January 2019 05:06
ResearchAndMarkets.comLaura Wood, Senior Press Manager This e-mail address is being protected from spambots. You need JavaScript enabled to view it For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Biomaterials
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 9 of 68

Newsletter